Original investigation
Reducing racial disparities in transplant activation:Whom should we target?

https://doi.org/10.1016/S0272-6386(05)80007-1Get rights and content

Abstract

Several studies have documented that blacks with end-stage renal disease (ESRD) are less likely than whites tobe placed on the waiting list for a renal transplant. We examined trends in access over time to determine whether publication of these reports resulted in a reduction in disparity and identified those blacks who were most affected to focus future interventions. Three nationally representative groups of adult patients with ESRD (first dialysis in 1986 to 1987, 1990, or 1993) were followed up longitudinally to ascertain the date of first placement on the renal transplant waiting list. Cox proportional hazards models were used to characterize the magnitude of racial disparities in access to the waiting list with adjustment for clinical and sociodemographic factors. Lower rates of placement on the waiting list for blacks than whites persisted after adjustment for differences in both sociodemographic characteristics and health status (relative hazard [RH], 0.68; 95% confidence interval [Cl], 0.59 to 0.79). The gap between blacks and whites did not narrow over time (blacks versus whites: 1986 to 1967 group, RH, 0.71; 95% CI, 0.59 to 0.86;1990 group, RH, 0.69; 95% CI, 0.54 to 0.91;1993 group, RH, 0.57; 0.43 to 0.77) and was greatest for the youngest and healthiest black patients, who were 50% and 40% less likely to be listed than corresponding whites, respectively. Interventions targeted toward young and healthy blacks, who are most likely to benefit from transplantation, are urgently needed to narrow black-white differences in transplant activation.

Presented in part at the 31st Annual Meeting of theAmerican Society of Nephrology, Philadelphia, PA, October 25–28, 1998.

The data reported here have been supplied by the USRenal Data System. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy of or interpretation by the US Government.

References (40)

  • KjellstrandC.M.

    Age, sex, and race inequality in renal transplantation

    Arch Intern Med

    (1988)
  • KallichJ.

    Access to Cadaveric Renal Transplantation

    (1993)
  • EggersP.W.

    Racial differences in access to kidney transplantation

    Health Care Financ Rev

    (1995)
  • AlexanderG.C. et al.

    Barriers to cadaveric renal transplantation among blacks, women, and the poor

    JAMA

    (1998)
  • Office of Inspector General

    The Access of Dialysis Patients to Kidney Transplantation

    (1987)
  • BlakesleeS.

    Studies find unequal access to kidney transplants

    New York Times

    (1989)
  • KasiskeB.L. et al.

    The effect of race on access and outcome in transplantation

    N Engl J Med

    (1991)
  • Office of Inspector General

    The Distribution of Organs for Transplantation: Expectations and Practices

    (1991)
  • RettigR. et al.

    Kidney Failure and the Federal Government

    (1991)
  • GaylinD.S. et al.

    The impact of comorbid and sociodemographic factors on access to renal transplantation

    JAMA

    (1993)
  • Cited by (47)

    • Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients

      2017, American Journal of Surgery
      Citation Excerpt :

      Multimodal interventions that focus on prevailing explanatory factors for these disparities are needed. Endeavors that limit the impact of socioeconomic and health care access disadvantages while also delivering a care model that is culturally acceptable and patient-centric are needed if researchers hope to substantially improve equity in transplant access on outcomes.8,34–37 The strengths of this analysis are that it includes a detailed assessment of all contemporary adult patients undergoing solitary renal transplantation within the United States; thus, the study population is a full representation of the target population.

    View all citing articles on Scopus

    Supported in part by grant no. K24DKO2643 the National Institute of Diabetes and Digestive and Kidney Diseases (N.R.P.). PPG was a Robert Wood Johnson Foundation Clinical Scholar.

    View full text